Campbell & CO Investment Adviser LLC bought a new stake in shares of Agilent Technologies Inc (NYSE:A) in the third quarter, Holdings Channel reports. The fund bought 2,118 shares of the medical research company’s stock, valued at approximately $214,000.
Several other institutional investors have also recently made changes to their positions in A. Blue Square Asset Management LLC acquired a new stake in shares of Agilent Technologies in the second quarter valued at about $25,000. Ameritas Investment Company LLC raised its holdings in Agilent Technologies by 169.1% in the 1st quarter. Ameritas Investment Company LLC now owns 444 shares of the medical research company’s stock valued at $31,000 after acquiring an additional 279 shares during the last quarter. Patriot Financial Group Insurance Agency LLC lifted its stake in Agilent Technologies by 1,570.8% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 401 shares of the medical research company’s stock worth $35,000 after purchasing an additional 377 shares in the last quarter. Sterling Investment Advisors Ltd. acquired a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $35,000. Finally, TCTC Holdings LLC purchased a new stake in shares of Agilent Technologies in the second quarter valued at approximately $41,000.
A number of equities analysts have weighed in on the company. Needham & Company LLC reissued a “hold” rating on shares of Agilent Technologies in a research note on Wednesday, August 19th. SVB Leerink upped their price target on Agilent Technologies from $95.00 to $100.00 and gave the company an “outperform” rating in a research note on Wednesday, August 19th. Citigroup boosted their price target on shares of Agilent Technologies from $85.00 to $100.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 19th. Bank of America increased their price objective on Agilent Technologies from $99.00 to $103.00 and gave the company a “neutral” rating in a research note on Wednesday, August 19th. Finally, BofA Securities boosted their target price on Agilent Technologies from $99.00 to $103.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 19th. Fifteen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $87.95.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, August 18th. The medical research company reported $0.78 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.12. The company had revenue of $1.26 billion during the quarter, compared to the consensus estimate of $1.21 billion. Agilent Technologies had a net margin of 13.23% and a return on equity of 20.57%. The company’s revenue for the quarter was down .8% on a year-over-year basis. During the same period last year, the firm earned $0.76 EPS. On average, equities research analysts expect that Agilent Technologies Inc will post 3.22 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, October 5th. This represents a $0.72 annualized dividend and a yield of 0.67%. Agilent Technologies’s dividend payout ratio is presently 23.15%.
In other Agilent Technologies news, VP Rodney Gonsalves sold 6,191 shares of the firm’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $98.17, for a total transaction of $607,770.47. Following the completion of the transaction, the vice president now owns 48,334 shares of the company’s stock, valued at $4,744,948.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Dominique Grau sold 6,485 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $100.00, for a total value of $648,500.00. Following the completion of the sale, the senior vice president now owns 104,154 shares in the company, valued at $10,415,400. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 85,392 shares of company stock worth $8,219,555.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.